Neurotransmitter receptor proteins are critical to learning and memory. Mutations are associated with neurological and neuropsychiatric conditions including Alzheimer’s, epilepsy, and autism. Structures of two such receptors, solved by x-ray crystallography, provide a blueprint for the development of therapeutics. Read more »
Designer Proteins Target Epstein-Barr-Virus-Associated Cancer
Researchers used new protein design approaches to develop a potential inhibitor of Epstein-Barr-Virus-associated cancer. The study shows not just how to help defeat the virus, but also opens up a whole new way to design proteins against viruses and ultimately, cancer. Read more »
Validating Computer-Designed Proteins for Vaccines
Computationally designed proteins that accurately mimic key viral structures can help produce better vaccines. The resulting protein structures, validated at the ALS, encourage the further development of this strategy for a variety of vaccine targets, including HIV and influenza. Read more »
Genentech Uses ALS Crystallography for Therapeutic Antibody Research
Genentech has developed a unique one-armed antibody, onartuzumab, which is now in late-stage clinical trials in multiple cancer types. The company used crystal structures obtained at ALS Beamline 5.0.2 to demonstrate the mechanism of action of this unique potentially therapeutic antibody. Read more »
The Path of Messenger RNA through the Ribosome
Using x-ray crystallography, researchers directly observed the path of mRNA in the 70S ribosome in Fourier difference maps at 7 Å resolution. Image depicts the view down the crystallographic 4-fold axis of the 70S ribosome-mRNA-tRNA complex, showing the head-to-tail juxtaposition of the model mRNAs (red-orange) between adjacent ribosomes. Read more »
- « Previous Page
- 1
- …
- 4
- 5
- 6